Epizyme (NASDAQ:EPZM) reported its Q4 earnings results on Tuesday, March 1, 2022 at 06:30 AM.
Here's what investors need to know about the announcement.
Earnings
Epizyme missed estimated earnings by 8.89%, reporting an EPS of $-0.49 versus an estimate of $-0.45.
Revenue was up $3.21 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.16 which was followed by a 0.41% drop in the share price the next day.
Here's a look at Epizyme's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | -0.48 | -0.62 | -0.58 | -0.58 |
| EPS Actual | -0.64 | -0.63 | -0.69 | -0.65 |
| Revenue Estimate | 13.18M | 8.72M | 6.56M | 6.19M |
| Revenue Actual | 5.20M | 13.01M | 7.63M | 8.38M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
